Captario’s AI Model Guide eliminates black-box fears by making complex models transparent—offering clear explanations and visuals to build trust and clarity in portfolio decisions.

Capturing operational risks—like delays and cost overruns—in forecasting models improves decision quality, uncovers hidden threats, and strengthens strategic planning across portfolios.

At the recent Vegas PPM conference, I shared a case study highlighting the importance of nuanced modeling for strategic decision-making. The scenario involved deciding whether to sequence NDA submissions for the two indications or file them in parallel. After completing a successful Phase 3 trial for Indication A, the team faced two options: ➡️ Wait for Indication B’s trial to finish and file both NDAs together (parallel filing). ➡️ File the NDA for Indication A immediately a

As the holiday season approaches, I wanted to share an exciting update on something we’ve been working on at Captario: Project Generators. This is an early gift for anyone tackling pipeline renewal, closing revenue gaps, or exploring innovative investment strategies to strengthen their portfolio. Project Generators are exactly what the name suggests—a feature inside Captario SUM that allows users to generate new projects based on customizable templates. These projects are aut

In many cases, the only risk quantified in development project investment cases is PTRS (Probability of Technical and Regulatory Success). While technical failures are leading reasons for project cancellations, other critical risks often go unaddressed. Here are three additional types of risks we discussed in the presentation: 👉 Operational Risks These include delays in timelines and increases in development costs. Timeline delays harm project value by delaying revenue and p

Captario SUM now offers centralized portfolio-level dependency modeling, helping teams manage interdependencies, toggle assumptions, and reduce risk across drug development portfolios.